Last update 20 Mar 2025

ELGN-2112

Overview

Basic Info

Drug Type
Hormone
Synonyms
Target-
Action-
Mechanism-
Therapeutic Areas
Congenital DisordersDigestive System DisordersEndocrinology and Metabolic Disease+ [1]
Active Indication
Fetal Growth RetardationMalabsorption SyndromesObstetric Labor, Premature
Inactive Indication-
Originator Organization
Elgan Pharma Ltd.Elgan Pharma Ltd.Startup
Active Organization
Elgan Pharma Ltd.Elgan Pharma Ltd.Startup
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with ELGN-2112
NCT05904626
/ Not yet recruitingPhase 2
A Multi-center, Double-Blind, Randomized, Two-Arm, Parallel-Group, Placebo Controlled Basket Study to Assess the Safety of ELGN-2112 in Preterm Infants Born Under 26 Weeks GA and IUGR Infants Born 26-32 Weeks GA
NL-OMON53321
/ SuspendedPhase 2
A Multi-center, Double-Blind, Randomized, Two-Arm, Parallel-Group, Placebo Controlled Basket Study to Assess the Safety of ELGN-2112 in Populations of Interest - FIT-05
100 Clinical Results associated with ELGN-2112
Login to view more data
100 Translational Medicine associated with ELGN-2112
Login to view more data
100 Patents (Medical) associated with ELGN-2112
Login to view more data
100 Deals associated with ELGN-2112
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Fetal Growth RetardationPhase 2-
Elgan Pharma Ltd.Elgan Pharma Ltd.Startup
01 May 2025
Malabsorption SyndromesPhase 2-
Elgan Pharma Ltd.Elgan Pharma Ltd.Startup
01 May 2025
Obstetric Labor, PrematurePhase 2-
Elgan Pharma Ltd.Elgan Pharma Ltd.Startup
01 May 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free